You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MDS/myeloproliferative neoplasm-unclassifiable (MDS/MPN-unclassifiable)

Showing 1 - 25 of 1,667
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

Recruiting
  • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 6, 2023

MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Feb 16, 2023

MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)

Recruiting
  • MDS/MPN
  • Azacitidine (AZA) with Ruxolitinib
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Apr 17, 2023

MDS, Myeloproliferative Tumor Trial in United States (Azacitidine Subcutaneous Injection or Intravenous Infusion, Pevonedistat

Active, not recruiting
  • Myelodysplastic Syndromes
  • Myeloproliferative Neoplasm
  • Azacitidine Subcutaneous Injection or Intravenous Infusion
  • +2 more
  • Miami, Florida
  • +4 more
Jun 20, 2022

Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

Recruiting
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Epidemiological and Clinical-pathological Factors of

Completed
  • Myeloproliferative Neoplasm
  • +4 more
    • Guayaquil, Guayas, Ecuador
      Sociedad de Lucha Contra el Cáncer
    Apr 25, 2023

    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Myeloproliferative Tumor (MDS/MPN) Trial in Durham (ADCT-301)

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • +2 more
    • Durham, North Carolina
      Duke University Health System
    Jan 10, 2022

    MDS, Myeloproliferative Tumors, Myelofibrosis Trial (Jaktinib, azacitidine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • (no location specified)
    Nov 29, 2021

    Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts Trial (Biospecimen

    Not yet recruiting
    • Chronic Myelomonocytic Leukemia
    • +3 more
    • Biospecimen Collection
    • +3 more
    • (no location specified)
    Oct 27, 2022

    Myeloproliferative Tumor, Chronic Neutrophilic Leukemia, MDS Trial in Tampa (Fedratinib Pill)

    Recruiting
    • Myeloproliferative Neoplasm
    • +2 more
    • Fedratinib Pill
    • Tampa, Florida
      Moffitt Cancer Center
    Jun 15, 2022

    National Center for Precision Medicine in Leukemia

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +4 more
    • Biobanking
    • (no location specified)
    Jun 7, 2022

    Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

    Recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 18, 2022

    Acute Myeloid Leukemia, Myeloproliferative Tumor, Myelodysplastic/Myeloproliferative Tumor Trial in Canada, United States

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Birmingham, Alabama
    • +9 more
    Aug 30, 2021

    Iron Deficiency Anemia Trial in Australia, Israel, Romania (KER-047)

    Recruiting
    • Iron Deficiency Anemia
    • Adelaide, South Australia, Australia
    • +8 more
    Jun 23, 2023

    Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

    Completed
    • Myelodysplastic/Myeloproliferative Neoplasm
    • +2 more
    • Decidual stromal cells (DSC)
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jan 8, 2023

    Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

    Recruiting
    • Primary Myelofibrosis
    • +9 more
    • Observational
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 11, 2022

    Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid Trial in Boston (Cytokine Induced Memory-like Natural Killer Cells,

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Cytokine Induced Memory-like Natural Killer Cells
    • Interleukin-2
    • Boston, Massachusetts
    • +1 more
    Nov 14, 2023

    GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

    Recruiting
    • GVHD
    • +15 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 30, 2021

    Acute Myeloid Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumor Trial in Worldwide (BGB-11417, Azacitidine, Posaconazole)

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Houston, Texas
    • +23 more
    Aug 18, 2022

    Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

    Not yet recruiting
    • Clonal Cytopenia of Undetermined Significance
    • +4 more
    • Biospecimen Collection
    • +6 more
    • Los Angeles, California
    • +1 more
    Oct 4, 2023

    Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

    Recruiting
    • Myeloproliferative Neoplasm
    • +7 more
      • Hong Kong, Hong Kong
        Department of Medicine, Queen Mary Hospital
      May 21, 2023

      Acute Myeloid Leukemia in Remission, Chronic Myelomonocytic Leukemia, Minimal Residual Disease Trial in Seattle (procedure,

      Active, not recruiting
      Has Results
      • Acute Myeloid Leukemia in Remission
      • +5 more
      • Allogeneic Bone Marrow Transplantation
      • +5 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      May 13, 2021

      Leukemia, Myelomonocytic, Chronic Trial in United States (Tipifarnib)

      Completed
      • Leukemia, Myelomonocytic, Chronic
      • Scottsdale, Arizona
      • +7 more
      May 12, 2021

      Myelodysplastic/Myeloproliferative Tumors, Adult Trial in Suzhou (venetoclax combined with azacitidine)

      Enrolling by invitation
      • Myelodysplastic/Myeloproliferative Neoplasms
      • Adult
      • venetoclax combined with azacitidine
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University, Jiangsu Ins
      Mar 7, 2022

      Leukemia, Lymphoma, Multiple Myeloma Trial in Omaha (CHAMPS-II adapted to adults 60+ years in HCT setting, Survivorship

      Recruiting
      • Leukemia
      • +4 more
      • CHAMPS-II adapted to adults 60+ years in HCT setting
      • Survivorship education active control
      • Omaha, Nebraska
        University of Nebraska Medical Center
      Nov 26, 2021